Literature DB >> 30565469

Female Sex Hormones Activate Human Endogenous Retrovirus Type K Through the OCT4 Transcription Factor in T47D Breast Cancer Cells.

Tam D Nguyen1, James Davis1, Roelle A Eugenio1, Yingguang Liu1.   

Abstract

Female sex hormones, the octamer-binding transcription factor 4 (OCT4), and human endogenous retroviruses (HERVs) are all involved in the development of breast cancer. However, whether there are cross talks between these factors to promote breast cancer is still unknown. Using the T47D human breast cancer cell line, we have found that estradiol and progesterone synergistically activate HERV-K through nuclear receptors. The progesterone receptor (isoform B) binds a progesterone-response element (PRE) in a long terminal repeat (LTR5HS) of HERV-K. There is another transcription factor-binding element in the LTR, the octamer motif, which is required for the hormones to activate gene transcription downstream of the LTR. Gel shift assays and co-immunoprecipitation indicate that the progesterone receptor (PR) and the OCT4 transcription factor interact on the protein level. Methylation of the PRE enhances binding of the PR. These findings help to elucidate the previously unknown cross talks among the sex hormones, OCT4, and HERVs in contributing to breast cancer proliferation and tumorigenesis, which may be useful in guiding further development of cancer therapies.

Entities:  

Keywords:  DNA methylation; breast cancer; endogenous retrovirus; estradiol; progesterone; transcription factor Oct4

Mesh:

Substances:

Year:  2019        PMID: 30565469     DOI: 10.1089/AID.2018.0173

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Human Endogenous Retroviruses Are Preferentially Expressed in Mononuclear Cells From Cord Blood Than From Maternal Blood and in the Fetal Part of Placenta.

Authors:  Massimiliano Bergallo; Luca Marozio; Giovanni Botta; Annalisa Tancredi; Valentina Daprà; Ilaria Galliano; Paola Montanari; Alessandra Coscia; Chiara Benedetto; Pier Angelo Tovo
Journal:  Front Pediatr       Date:  2020-05-14       Impact factor: 3.418

Review 2.  Human Endogenous Retroviruses as Gene Expression Regulators: Insights from Animal Models into Human Diseases.

Authors:  Serpen Durnaoglu; Sun-Kyung Lee; Joohong Ahnn
Journal:  Mol Cells       Date:  2021-12-31       Impact factor: 5.034

3.  A Systematic Review of Expression and Immunogenicity of Human Endogenous Retroviral Proteins in Cancer and Discussion of Therapeutic Approaches.

Authors:  Mikkel Dons Müller; Peter Johannes Holst; Karen Nørgaard Nielsen
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

4.  Dolutegravir Inhibits Proliferation and Motility of BT-20 Tumor Cells Through Inhibition of Human Endogenous Retrovirus Type K.

Authors:  Jiayi Li; John Lin; John R Lin; Mason Farris; Lauren Robbins; Leo Andrada; Bryce Grohol; Serrat Nong; Yingguang Liu
Journal:  Cureus       Date:  2022-07-03

5.  Repetitive Sequence Transcription in Breast Cancer.

Authors:  Walter Arancio; Claudia Coronnello
Journal:  Cells       Date:  2022-08-14       Impact factor: 7.666

Review 6.  Transcriptional Regulation of Endogenous Retroviruses and Their Misregulation in Human Diseases.

Authors:  Qian Zhang; Juan Pan; Yusheng Cong; Jian Mao
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

7.  Human Endogenous Retrovirus Expression Is Upregulated in the Breast Cancer Microenvironment of HIV Infected Women: A Pilot Study.

Authors:  Gislaine Curty; Greta A Beckerle; Luis P Iñiguez; Robert L Furler; Pedro S de Carvalho; Jez L Marston; Stephane Champiat; Jonas J Heymann; Christopher E Ormsby; Gustavo Reyes-Terán; Marcelo A Soares; Douglas F Nixon; Matthew L Bendall; Fabio E Leal; Miguel de Mulder Rougvie
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

8.  Retroviral Elements in Human Evolution and Neural Development.

Authors:  Tongguang Wang; Tara T Doucet-O'Hare; Lisa Henderson; Rachel P M Abrams; Avindra Nath
Journal:  J Exp Neurol       Date:  2021
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.